BioSwan is first CAR-T concomitant detection regent entered the National Special Review for Innovative Medical Devices

As announced by Center for Medical Device Evaluation(CMDE) of National Medical Products Administration (NMPA), BioSwan is CAR-T cellular therapy flow cytometry kit has successfully passed the application for special review of national Innovative Medical Devices. Which is the first clinical detection product for CAR-T cellular therapy that enters the innovative "green channel" in China.

Our Mission
Serving the entire process based on precise detection for cellular drug from R&D to marketing
ACCURATE DETECTION REAGENTS & TECHNICAL SOLUTIONS
SPECIFIC DETECTION REAGENTS
PRECISE DETECTION SOLUTIONS
DIGITAL MANAGEMENT PLATFORM